Villepinte (France), January 28, 2021 (8:00 a.m. CET)-Guerbet (FR0000032526 GBT), a global leader in medical imaging, has announced the appointment of Sarah Dayre to the Executive Committee as Senior Vice President of Technical Operations, managing production, the supply chain and quality. Sarah will take up her new position on February 1 and will report directly to David Hale, CEO.
Sarah Dayre is a Doctor of pharmacy and a graduate of ENSIC in France (Process engineering).
She has gained over 20 years' experience of pharmaceutical manufacturing and the global supply chain working for AstraZeneca in Europe and Asia.
The right combination of workflow, clinical equipment and technology can improve patient care, clinical outcomes and your bottom line. Click above to learn more.
In 2017 she was appointed head of operations of the Wuxi site in China, in charge of regional and global markets.
"Sarah is a leader with extensive pharmaceutical expertise and I'm delighted to welcome her to our Executive Committee, where she will play a key role in helping us to meet the ambitious organizational efficiency targets set for our industrial operations, required to achieve our transformation," said David Hale.
Guerbet is a leader in medical imaging worldwide, offering a wide range of pharmaceutical products, medical devices, digital and AI solutions for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients. A pioneer since more than 90 years in the field of contrast media with over 2,800 people globally, Guerbet is continuously innovating with 9% of revenue dedicated to Research & Development and four centers in France, Israel and the United States. Guerbet (GBT) is listed on Euronext Paris (segment B - mid caps) and generated €817 million in revenue in 2019. For more information about Guerbet, please visit www.guerbet.com.